Skip to Content

Publications, Presentations & Leadership

Recent Publications

1. Mulligan WA, Wegner KA, Keil KP, Mehta V, Taketo MM, Vezina CM. Beta-catenin and estrogen signaling collaborate to drive cyclin D1 expression in developing mouse prostate. Differentiation 2017 Jan – Feb; 93():66-71.
[PubMed ID: 27918915, PMCID: 5285441]
More Information
2. Liu TT, Grubisha MJ, Frahm KA, Wendell SG, Liu J, Ricke WA, Auchus RJ, DeFranco DB. Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-Reductase Inhibition in Prostate Epithelial Cells. J. Biol. Chem. 2016 Jul 08; 291(28):14747-60.
[PubMed ID: 27226548, PMCID: 4938192]
More Information
3. Jeong CH, Gao L, Dettro T, Wagner ED, Ricke WA, Plewa MJ, Flaws JA. Monohaloacetic acid drinking water disinfection by-products inhibit follicle growth and steroidogenesis in mouse ovarian antral follicles in vitro. Reprod. Toxicol. 2016 Jul; 62():71-6.
[PubMed ID: 27151372, PMCID: 4905796]
More Information
4. Bauman TM, Ricke EA, Drew SA, Huang W, Ricke WA. Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging. J Vis Exp 2016 Apr 08; (110):.
[PubMed ID: 27167094, PMCID: 4913774]
More Information
5. Thomas S, Hao L, Ricke WA, Li L. Inside back cover: Biomarker discovery in mass spectrometry-based urinary proteomics. Proteomics Clin Appl 2016 Apr; 10(4):NA.
[PubMed ID: 27061328]
More Information
6. Thomas S, Hao L, Ricke WA, Li L. Biomarker discovery in mass spectrometry-based urinary proteomics. Proteomics Clin Appl 2016 Apr; 10(4):358-70.
[PubMed ID: 26703953, PMCID: 4888976]
More Information
7. Ricke WA, Lee CW, Clapper TR, Schneider AJ, Moore RW, Keil KP, Abler LL, Wynder JL, López Alvarado A, Beaubrun I, Vo J, Bauman TM, Ricke EA, Peterson RE, Vezina CM. In Utero and Lactational TCDD Exposure Increases Susceptibility to Lower Urinary Tract Dysfunction in Adulthood. Toxicol. Sci. 2016 Apr; 150(2):429-40.
[PubMed ID: 26865671, PMCID: 4900134]
More Information
8. Bauman TM, Vezina CM, Ricke EA, Halberg RB, Huang W, Peterson RE, Ricke WA. Expression and colocalization of β-catenin and lymphoid enhancing factor-1 in prostate cancer progression. Hum. Pathol. 2016 May; 51():124-33.
[PubMed ID: 27067790, PMCID: 4830919]
More Information
9. Wynder JL, Nicholson TM, DeFranco DB, Ricke WA. Estrogens and Male Lower Urinary Tract Dysfunction. Curr Urol Rep 2015 Sep; 16(9):61.
[PubMed ID: 26156791, PMCID: 4732275]
More Information
10. Greer T, Hao L, Nechyporenko A, Lee S, Vezina CM, Ricke WA, Marker PC, Bjorling DE, Bushman W, Li L. Custom 4-Plex DiLeu Isobaric Labels Enable Relative Quantification of Urinary Proteins in Men with Lower Urinary Tract Symptoms (LUTS). PLoS ONE 2015; 10(8):e0135415.
[PubMed ID: 26267142, PMCID: 4534462]
More Information
11. Begley LA, Kasina S, Shah RB, Macoska JA. Signaling mechanisms coupled to CXCL12/CXCR4-mediated cellular proliferation are PTEN-dependent. Am J Clin Exp Urol 2015; 3(2):91-9.
[PubMed ID: 26309898, PMCID: 4539110]
More Information
12. Bauman TM, Ewald JA, Huang W, Ricke WA. CD147 expression predicts biochemical recurrence after prostatectomy independent of histologic and pathologic features. BMC Cancer 2015 Jul 25; 15():549.
[PubMed ID: 26209327, PMCID: 4514016]
More Information
13. Bjorling DE, Wang Z, Vezina CM, Ricke WA, Keil KP, Yu W, Guo L, Zeidel ML, Hill WG. Evaluation of voiding assays in mice: impact of genetic strains and sex. Am. J. Physiol. Renal Physiol. 2015 Jun 15; 308(12):F1369-78.
[PubMed ID: 25904700, PMCID: 4469884]
More Information
14. Keil KP, Abler LL, Altmann HM, Wang Z, Wang P, Ricke WA, Bjorling DE, Vezina CM. Impact of a folic acid-enriched diet on urinary tract function in mice treated with testosterone and estradiol. Am. J. Physiol. Renal Physiol. 2015 Jun 15; 308(12):F1431-43.
[PubMed ID: 25855514, PMCID: 4469891]
More Information
15. Theberge AB, Yu J, Young EW, Ricke WA, Bushman W, Beebe DJ. Microfluidic multiculture assay to analyze biomolecular signaling in angiogenesis. Anal. Chem. 2015 Mar 17; 87(6):3239-46.
[PubMed ID: 25719435, PMCID: 4405103]
More Information
16. Bauman TM, Vezina CM, Huang W, Marker PC, Peterson RE, Ricke WA. Beta-catenin is elevated in human benign prostatic hyperplasia specimens compared to histologically normal prostate tissue. Am J Clin Exp Urol 2014; 2(4):313-22.
[PubMed ID: 25606577, PMCID: 4297327]
More Information
17. Keil KP, Abler LL, Altmann HM, Bushman W, Marker PC, Li L, Ricke WA, Bjorling DE, Vezina CM. Influence of animal husbandry practices on void spot assay outcomes in C57BL/6J male mice. Neurourol. Urodyn. 2016 Feb; 35(2):192-8.
[PubMed ID: 25394276, PMCID: 4428995]
More Information
18. Bauman TM, Nicholson TM, Abler LL, Eliceiri KW, Huang W, Vezina CM, Ricke WA. Characterization of fibrillar collagens and extracellular matrix of glandular benign prostatic hyperplasia nodules. PLoS ONE 2014; 9(10):e109102.
[PubMed ID: 25275645, PMCID: 4183548]
More Information
19. Nicholson TM, Moses MA, Uchtmann KS, Keil KP, Bjorling DE, Vezina CM, Wood RW, Ricke WA. Estrogen receptor-α is a key mediator and therapeutic target for bladder complications of benign prostatic hyperplasia. J. Urol. 2015 Feb; 193(2):722-9.
[PubMed ID: 25167991, PMCID: 4305478]
More Information
20. Powers GL, Hammer KD, Domenech M, Frantskevich K, Malinowski RL, Bushman W, Beebe DJ, Marker PC. Phosphodiesterase 4D inhibitors limit prostate cancer growth potential. Mol. Cancer Res. 2015 Jan; 13(1):149-60.
[PubMed ID: 25149359, PMCID: 4312503]
More Information
21. Gharaee-Kermani M, Mehra R, Robinson DR, Wei JT, Macoska JA. Complex cellular composition of solitary fibrous tumor of the prostate. Am. J. Pathol. 2014 Mar; 184(3):732-9.
[PubMed ID: 24434011, PMCID: 3936322]
More Information


Scientific Presentations/Outreach

1. Vanderbilt Center for Benign Urologic Diseases, Nashville, TN. “Emerging Players in Urinary Dysfunction: Epigenetics and Sleep Apnea." May 2014, Chad Vezina.

2. School of Veterinary Medicine, University of Wisconsin-Madison, WI. “Prostate Research in the Vezina Lab: Past, Present, and Future.” November 2014, Chad Vezina.

3. NIH/NIDDK Urology Developmental Centers Meeting, Pacific Grove, CA. “Developmental Mapping of the Prostate.” December 2014, Chad Vezina.

4. University of Chicago, Chicago IL. “Mapping the Developing Mouse Prostate to Reveal New Ductal Growth Mechanisms: A Focus on DNA Methylation.” February 2015, 2016.

5. NIH/NIDDK Urology Developmental Centers Meeting, Pacific Grove, CA. “Urinary Biomarkers of Lower Urinary Tract Symptoms (LUTS) in Men.” December 2014, Paul Marker.

6. UW-Madison/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease. Madison, WI. “Impact of AHR Signaling on Benign Urinary Function.” April 2016, Chad Vezina.

7. University of Wisconsin-Madison Endocrinology and Reproductive Physiology Annual Symposium, “Unraveling the Connection between Prostate and Urinary Dysfunction.” June 2016, Chad Vezina.

8. NIH/NIDDK Urology Developmental Centers Meeting, Madison, WI. “Roles of Beta-catenin in Urinary Dysfunction.” September 2015, Chad Vezina.

9. Columbia University, Symposium on the Genetic Origins and Complications of Urinary Tract Abnormalities, New York, NY. “A Role for DNA Methylation in Prostate Development and Urinary Function.” November 2015, Chad Vezina.

10. Society for Basic Urologic Research (SBUR) Fall Symposium, Ft. Lauderdale, FL. “The Influence of Intermittent Hypoxia and Diabetes on Lower Urinary Tract Function.” November 2015, Chad Vezina.

11. University of Illinois Chicago Medical School (Rockford satellite), Rockford, IL, October 7, 2015. “Identifying molecular mechanisms of prostate cancer and BPH using mouse models.” Paul Marker.

12. University of Massachusetts Boston, Boston, MA, December 7, 2015. “Identifying molecular mechanisms of prostate cancer using transposon-mediated mutagenesis and mouse models.” Paul Marker.

13. NIH/NIDDK Conference on Urinary Obstruction and Fibrosis, Targeting Fibrosis in Kidney, Bone Marrow, and Urological Diseases, Bethesda, MD. January 7, 2014, Jill Macoska.

14. The University of Wisconsin Symposium, Role of Fibrosis in Signaling and Lower Urinary Tract Disease, April 8-9, 2015, Madison, WI, Jill Macoska.

15. The Society for Urodynamics and Female Urology (SUFU) Annual Meeting, February 23-27, 2016, New Orleans, LA. Invited Talk: “Urinary Obstruction and Fibrosis,” Jill Macoska.

16. University of Wisconsin-Molecular Environmental Toxicology Center, “Aryl hydrocarbon Receptor mediation in lower urinary tract dysfunction,” September, 2014, Will Ricke.

17. University of Wisconsin Department of Urology Uehling Lectures. “Hormones and BPH: Glandular Growth and/or Fibrosis.” October 24, 2014, Will Ricke.

18.Clark-Atlanta University, Atlanta, GA, Graduate student and postdoc association, “Hormone action and paracrine interactions in prostatic carcinogenesis," February 6, 2015, Will Ricke.

19. University of Wisconsin-O’Brien Center, “Prostatic fibrosis as a mediator of prostate disease,” April 2015, Will Ricke.

20. American Urological Association, Estrogen Regulation in BPH and the Lower Urinary Tract, New Orleans, LA May, 2015, Will Ricke.

21. Society of Basic Urologic Research, “Estrogen regulation and fibrosis in lower urinary tract dysfunction," Dallas, TX Fall 2014, Will Ricke.

22. American Urologic Association, Basic Science Symposium, “Estrogen Regulation in the Prostate,” New Orleans, LA, 2015, Will Ricke.

23. UW-Madison/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease. Madison, WI. “Estrogen Induction of LUTD in Mice.” April 2016, Will Ricke.

24. NIH/NIDDK Urology Developmental Centers Meeting, Madison, WI. “Estrogen Action in Urinary Dysfunction.” September 2015, Will Ricke.

25. NIH/NIDDK Urology Centers Steering Committee Meeting, Bethesda, MD, June 2015. “Overview of O’Brien Center.” Will Ricke.

26. Duke University, Multidisciplinary Benign Urology Research Day, KURe and PMRC, Key note speaker, “Hormonal Regulation and Fibrosis in the Lower Urinary Tract.” April 29, 2016, Will Ricke.

27. American Urologic Association, Plenary session. “Patient Stratification in the Treatment of BPH." San Diego, CA, 2016, Will Ricke.

28. O’Brien Center Retreat, “Progress and Future of the UW-Madison & UM-Boston O’Brien Center,” August 2015, Will Ricke.

29. National Institute of Environmental Health Sciences, Consortium Linking Academic and Regulatory Insights on BPA
Toxicity (CLARITY-BPA), “Estrogenic Effects of BPA on the Lower Urinary Tract of Postnatal Day 1 Rats.” November 2015, Will Ricke.

30. University of Wisconsin-Department of Urology Grand Rounds, “Modeling Prostate Disease in Mice and Cell Culture,” Will Ricke.

31. SBUR Fall Meeting, “Inflammation of the Lower Urinary Tract,” November 2015, Dale Bjorling.

32. Urology Program Directors Meeting, Wisconsin K12cure Program, September 2015, Madison, WI, Dale Bjorling.


Abstracts

1. Gamat M, Parkhurst L, Steinke L, Marker PC. Ornithine Decarboxylase Activity Is Required for Prostatic Bud Initiation. 6th Great Lakes Nuclear Receptor Conference (GLNRC); Madison, WI; October 17-18, 2014.

2. Hao L, Greer T, Zhong X, Page D, Lee S, Vezina CM, Ricke WA, Parker PC, Bjorling DE, Bushman W, Li L. Combining DiLeu Isobaric Labeling and Label-free Approaches for Metabolite Quantification and Biomarker Discovery of Lower Urinary Tract Symptoms (LUTS). 63rd Annual ASMS Conference on Mass Spectrometry and Allied Topics; St. Louis, MO; May 2015.

3. Ricke WA, Lee C, Clapper T, Schneider A, Moore RW, Keil KP, Abler LL, Wynder J, López Alvarado A, Beaubrun I, Vo J, Peterson RE, Vezina CM. Fetal TCDD exposure increases adult male mouse susceptibility to urinary dysfunction. The 54th Annual Meeting of the Society of Toxicology; San Diego, CA; March 2015.

4. Hao L, Greer T, Vezina CM, Ricke WA, Marker PC, Bjorling DE, Bushman W, Li L. Identification of potential metabolite biomarkers of lower urinary tract symptoms (LUTS) in mouse and human urine. UW-O’Brien Center Spring Symposium; April 2015.

5. Wegner K, Vezina CM. Characterization of Stroma in Normal Mouse Prostate/Urethra and Mice with Urethral Obstruction. Society for Basic Urologic Research Fall Symposium; Ft. Lauderdale, FL; November 2015. Jeong CH, Vezina CM, Ricke WA. Alterations of DNA Methyltransferase in BPH-1 Derived Prostate Cancer Progression Model Cell Lines. Society for Basic Urologic Research Fall Symposium; Ft. Lauderdale, FL; November 2015.

6. Bauman TM, Vezina CM, Halberg RB, Huang W, Peterson RE, Ricke WA. Expression and Co-localization of Beta-Catenin and Lymphoid Enhancing Factor-1 in Prostate Cancer Progression. Society for Basic Urologic Research Fall Symposium; Ft. Lauderdale, FL; November 2015.

7. Joseph DB, Keil KP, Abler LL, Vezina CM. A map of DNA methyltransferase enzyme expression in the mouse prostate during its development and in response to prostate injury. WARF discovery challenge symposium; Madison, WI; April 2016.

8. Joseph DB, Keil KP, Abler LL, Vezina CM. A map of DNA methyltransferase enzyme expression in the mouse prostate during its development and in response to prostate injury. 2nd Annual George M. O’Brien Benign Urology Symposium, The Environmental Impact on Urologic Health and Disease; Madison, WI; April 2016.

9. Cadena M, Wegner KA, Bushman W, Ricke WA, Vezina CM. Elucidating Patterns of Smooth Muscle Contractility in Prostatic Urethral Tissue. 2nd Annual George M. O’Brien Benign Urology Symposium, The Environmental Impact on Urologic Health and Disease; Madison, WI; April 2016.

10. Oakes SR, Eliceiri K, Abler LL, Wagner KA, Vezina CM. Computer-Based High-Throughput Urinary Function Analysis. 2nd Annual George M. O’Brien Benign Urology Symposium, The Environmental Impact on Urologic Health and Disease; Madison, WI; April 2016.

11. Trevena R, Sullivan R, Wegner KA, Vezina CM, Vokoun C, Eliceiri K, Joseph DB. Optimization of whole-tissue immunohistochemical staining and fluorescence confocal scanning for 3-D prostatic microenvironmental analysis. 2nd Annual George M. O’Brien Benign Urology Symposium, The Environmental Impact on Urologic Health and Disease; Madison, WI; April 2016.

12. Jeong CH, Vezina CM, Ricke WA. Alterations of DNA methyltransferase in BPH-1 derived prostate cancer progression model cell lines. 2nd Annual George M. O’Brien Benign Urology Symposium, The Environmental Impact on Urologic Health and Disease; Madison, WI; April 2016.

13. Lamarre NS, Wynder J, Uchtmann K, Liu T, Wang Z, Vezina CM, Ricke WA, Bjorling DE. 2nd Annual George M. O’Brien Benign Urology Symposium, The Environmental Impact on Urologic Health and Disease; Madison, WI; April 2016.

14. Thomas S, Hao L, Greer T, Vezina CM, Bajpal S, Ashok A, Bieberich CJ, Ricke WA, Li L. The urine proteoms of genetically-induced lower urinary tract dysfunction (LUTD) mice. 2nd Annual George M. O’Brien Benign Urology Symposium, The Environmental Impact on Urologic Health and Disease; Madison, WI; April 2016.

15. Oakes SR, Eliceiri K, Abler LL, Wagner KA, Vezina CM. Computer-Based High-Throughput Urinary Function Analysis. Undergraduate Research Symposium; Madison, WI; April 2016.

16. Powers GL, Su X, Beebe D, and Marker PC. Developmental paracrine signaling pathways promote prostate cancer progression. AACR Developmental Biology and Cancer meeting; Nov. 30-Dec. 3, 2015; Boston, MA.

17. Powers GL, Su X, Domenech M, Beebe D, and Marker PC. Modeling paracrine signaling that promotes prostate cancer progression using microfluidics approaches. 2nd Annual Midwest Tumor Microenvironment Meeting; May 18-20, 2016; University of Minnesota– Twin Cities, Minneapolis, MN.

18. Ling Hao, Tyler Greer, Xuefei Zhong, David Page, Sanghee Lee, Chad Vezina, Will Ricke, Paul Marker, Dale Bjorling, Wade Bushman, Lingjun Li. Combining DiLeu Isobaric Labeling and Label-free Approaches for Metabolite Quantification and Biomarker Discovery of Lower Urinary Tract Symptoms (LUTS). Society for Mass Spectrometry conference (AAPS)

19. William A. Ricke, Calvin Lee, Tyler Clapper, Andrew Schneider, Robert W. Moore, Kimberly P. Keil, Lisa L. Abler, Jalissa Wynder, Arnaldo López Alvarado, Richard E. Peterson, Chad M. Vezina. Fetal TCDD exposure increases adult male mouse susceptibility to urinary dysfunction. Society of Toxicology.

20. Tristan M. Nicholson, Tyler M. Bauman, William A. Ricke. Bladder fibrosis observed in male mice treated with testosterone and estradiol is not prevented by the selective estrogen receptor modulator raloxifene. Society for Basic Urologic Research (SBUR).

21. Jalissa Wynder, Tristan Nicholson, Kristen Uchtmann, William A. Ricke. Testosterone and Bisphenol A Exposure Induces Increased Prostate Mass and Bladder Mass of Male Mice. Society for Basic Urologic Research (SBUR).

22. Tyler M. Bauman, BS, Jonathan A. Ewald, PhD, Wei Huang, MD, William A. Ricke. Lower CD147 expression is associated with advanced prostate cancer and predicts biochemical recurrence after prostatectomy independent of clinical and pathological features. Society for Basic Urologic Research (SBUR).

23. Ling Hao, Tyler Greer, Chad Vezina, Will Ricke, Paul Marker, Dale Bjorling, Wade Bushman, Lingjun Li. Identification of potential metabolite biomarkers of lower urinary tract symptoms (LUTS) in mouse and human urine. UW-O’Brien Center Symposium.

24. Jalissa Wynder, Tristan Nicholson, Kristen Uchtmann, William A. Ricke. Bisphenol A Exposure Induces LUTD in Male Mice. UW-O’Brien Center Symposium.

25. Ashleigh B. Theberge, Jiaquan Yu, Xiaojing Su, Edmond W. K. Young, William A. Ricke, Wade Bushman, and David J. Beebe. Examining microenvironmental regulation of angiogenesis in benign prostatic hyperplasia with microscale culture. UW-O’Brien Center Symposium.

26. Tyler M. Bauman*, Emily A. Ricke, Wei Huang, William A. Ricke. A tissue specific role for ligand independent ARv7 signaling in benign prostate pathogenesis. AUA Meeting.

27. Tristan Nicholson*, Jalissa Wynder, William Ricke. Estrogen receptor-alpha is necessary for hormonal induction of prostate growth in male mice. AUA Meeting.


Hosted Symposia & Seminars

1. January 21, 2015; Simon W. Hayward, PhD, Vanderbilt University, “Inflammation and androgen receptor variant expression in benign prostatic hyperplasia”

2. February 18, 2015; Rosalyn Adam, PhD, Harvard University, “Signaling networks in the bladder: implications for benign urologic disease”

3. March 9, 2015; Gail Risbridger, Professor, Director of Centre for Urologic Research and Monash University, “Patient Derived Xenografts: Preclinical Insights that Influence Clinical Practice”

4. April 8, 2015; Jill Macoska, UMASS Boston, “CXCL12-mediated non-canonical signaling promotes myofibroblast phenoconversion in the prostate”

5. CROSS NIH INSTITUTE INTERACTION: April 8, 2015; Tom Wynn, NIAID, “Targeting immunological mechanisms of fibrosis”

6. CROSS-DISCIPLINE INTERACTION: April 8, 2015; Patricia Keely, UW-Madison, "Molecular changes of fibrosis during mammary gland pathogenesis”

7. CROSS-DISCIPLINE INTERACTION: April 8, 2015; Linda Schuler, UW-Madison, “Matric Stiffness: Recruitment of Hormones to the Dark Side of Breast Cancer”

8. CROSS-DISCIPLINE INTERACTION: April 8, 2015; Paul Campagnola, UW-Madison, “High Resolution Imaging and Modeling Approaches to Study ECM Changes in Cancer, Fibrosis, and Connective Tissue Disorders”

9. April 9, 2015; Ben Humphreys, Harvard, “Resident Perivascular Cells and Organ Fibrosis”

10. April 9, 2015; Wei Huang, UW-Madison, “Characterization of Fibrillar Collagens and Extracellular Matrix of Glandular Benign Prostatic Hyperplasia Nodules”

11. April 9, 2015; Kevin Elicieri, UW-Madison, “Multiscale Imaging Approaches for Investigating ECM Changes in Disease”

12. INTERACTION WITH COLUMBIA O’BRIEN CENTER: April 10, 2015; Cathy Mendelsohn, Professor of Urology, Pathology & Cell Biology,(Institute of Human Nutrition) and Genetics & Development, U54 O’Brien Urology Research Center Director, Columbia University, “Progenitors important for formation and regeneration of the urothelium, and their contribution to bladder cancer”

13. May 6, 2015, Teresa Liu, PhD, University of Pittsburgh, “5α-reductase inhibition drives production of Erβ ligands via a COX-2 dependent mechanism in BPH

14. October 14, 2015, Douglas Strand, PhD, UT Southwestern Medical Center, “Dissecting the Pathogenesis of Clinical BPH”

15. INTERACTION WITH MAYO O’BRIEN CENTER: December 9, 2015, Michael F. Romero, PhD, Professor of Physiology & Biomedical Engineering and Nephrology & Hypertension, Mayo Clinic College of Medicine, “The Electrogenic Na+ Bicarbonate Cotransporter (NBCe1) – metabolic acidosis and glaucoma”

16. INTERACTION WITH FORMER WASHINGTON UNIVERSITY P20 CENTER: January 13, 2016, Jeffrey H. Miner, PhD, FASN, Professor of Medicine and of Cell Biology and Physiology, Washington University School of Medicine, “Roles of Basement Membranes in the Urogenital System”

17. February 10, 2016, Lingjun Li, PhD, Professor of Pharmaceutical Sciences and Chemistry, University of Wisconsin-Madison, “Developing Mass Spectometry-based Omics Strategies for Candidate Biomarker Discovery in Lower Urinary Tract Symptoms (LUTS) and Beyond”

18. INTERACTION WITH FORMER P20 CENTER: March 8, 2016, Anna Malykhina, PhD, Associate Professor of Urology University of Colorado School of Medicine, The Role of Neural Circuits in Regulation of Lower Urinary Tract Function”

19. April 4, 2016, Reginald Bruskewitz, UW-Madison, “Overview of BPH/LUTS: A Role for Compliance and Fibrosis”

20. CROSS NIH INSTITUTE INTERACTION: April 4, 2016, Rick Woychik, Deputy Director, NIEHS,“Toxicological Insights for Future Research.

21. April 4, 2016, Barry Timms, University of South Dakota, “The Role of Bisphenol-A in LUT Development and LUTD”

22. INTERACTION WITH GRADUATE TRAINEE: April 4, 2016, Jalissa Wynder, UW-Madison, “The Role of Bisphenol A in LUTD"

23. INTERACTION WITH GRADUATE TRAINEE: April 4, 2016, Jordan Vellky, UW-Madison, “BPA Exposure and Associated Gene Expression Changes in Prostate Cancer“

24. CROSS-DISCIPLINE INTERACTION: April 4, 2016, Weiping Tang, UW-Madison, “The Next Generation of SAhRM as Potential Therapeutics"

25. INTERACTION WITH GRADUATE TRAINEE: April 4, 2016, J*ustine Coburn*, UW-Madison, “ER and AhR Crosstalk in Breast Cancer”

26. April 4, 2016, Lingjun Li, UW-Madison, “Developing Mass Spectrometry-based Omics Strategies for Candidate Biomarker Discovery in LUTS"

27. April 4, 2016, Allison Brodbeck, UW-Madison “Ultrasound Imaging of the Mouse Renal System"

28. INTERACTION WITH GRADUATE TRAINEE: April 4, 2016, Kyle Wegner, UW-Madison, “Picrosirius Red: A Versatile Tool for Analyzing Collagen in the Lower Urinary Tract"

29. INTERACTION WITH EXTERNAL ADVISORY COMMITTEE (SITE VISIT): April 5, 2016, Shuk-Mei Ho, University of Cincinnati, “BPA Effects on Methylation in Reproductive Tissues"

30. April 5, 2016, John Denu, UW-Madison, “Histone-typing as an Epigenetic Tool in Diagnosis and Treatment"

31. INTERACTION WITH GRADUATE TRAINEE: April 5, 2016, Diya Binoy Joseph, UW-Madison, “Investigating the Role of DNA Methylation in Prostate Development and Disease”

32. CROSS-DISCIPLINE INTERACTION: April 5, 2016, Linda Schuler, UW-Madison, “Desmoplasia: Hijacking Hormones in Breast Cancer”

33. CROSS-DISCIPLINE INTERACTION: April 5, 2016, Wei Xu, UW-Madison, “Direct Estrogen Receptor Dimerization Using Chemical Probes”

34. INTERACTION WITH GRADUATE TRAINEE: April 5, 2016, Megan Livingston, UW-Madison, “Utilizing Micro-scale Tools to Identify Key Factors in the Microenvironment”

35. INTERACTION WITH UW-MADISON K12: April 5, 2016, Teresa Liu, UW-Madison, “Selective Estrogen Receptor Modulators and BPH”

36. INTERACTION WITH EXTERNAL ADVISORY COMMITTEE (SITE VISIT): May 11, 2016, Mark T. Nelson, PhD, University Distinguished Professor and Chair, Department of Pharmacology, University of Vermont, “Non-Voiding Contractions Encode Essential Information on Urinary Bladder Fullness”

37. INTERACTION WITH UW-MADISON K12: December 10, 2016, Teresa Liu, PhD, K12 scholar, “The role of estrogen receptor activation on BPH progression"

38. January 14, 2016, Neil Lamarre (Post-doctoral Fellow, Dale Bjorling Lab), “Relevance of Lower Urinary Tract Function Testing in Mice to Humans"

39. INTERACTION WITH TRAINEES: March 10, 2016, (mini-talks from Lisa Abler (scientist), Kyle Wegner (graduate student), Mark Cadena (Graduate Student) and Royal Oakes (Undergraduate)), “Urologic Research Tools in Development”

40. INTERACTION WITH UW-MADISON K12: April 14, 2016, Dr. Michael Wood (K12 scholar), “Barrier function in bladder disease"

41. May 12, 2016, Dr. Jay Reeder, University of Rochester, “The role of SCN9A in pain perception and interstitial cystitis”


Service & Leadership

2014-2016   Vice-President, President, Past President, the Society for Basic Urologic Research, Jill Macoska

2014   Member, Review Panel, NIH/NIDDK ZDK1 GRB-S (M1), NIDDK Central Repositories Non-Renewable Sample Access, Jill Macoska

2014   Member, Review Panel, NIH/NIDDK ZDK1 GRB-S (O5), Novel Methods for Measurement of Organ Fibrosis (U01), Jill Macoska

2015   Member, Review Panel, NIH/NIDDK ZDK1 GRB-3 (01), U54 Urology Research Center Applications, Jill Macoska

2016   Chair, Organizing Committee, Basic Science Symposium, American Urological Association Annual Meeting, San Diego, CA, Jill Macoska

2016   Member, Review Panel, 2016/10 ZRG1 DKUS-G (90) S Urologic and Urogynecologic Applications, Jill Macoska

2016   Member, Review Panel, 2016/10 ZDK1 GRB-3 (O2) 1 George M. O’Brien Urology Cooperative Research Centers Program (U54), Jill Macoska

2015   Planning committee, Society for Basic Urologic Research Fall Meeting, Chad Vezina

2015   Session Chair, NIDDK Meeting Establishing the Parameters of Void Spot Assays and Cystometrograms for Data Sharing, Baltimore, MD, Chad Vezina

2015   SBUR Membership Committee, August 2015 to present, Dale Bjorling

2016   Member, Review Panel, NIH, ZDK1 GRB-2 (M3) GUDMAP RFA, Bethesda, MD, March 9, 2016, Dale Bjorling

2015   Session Chair, Discussion Forum: Emerging Model Systems for Research. SBUR Fall Symposium, Ft. Lauderdale, FL, Chad Vezina

2015   Session Chair, Cell-Specific Responses to Comorbidities in BPH. SBUR Fall Symposium, Ft. Lauderdale, FL, Chad Vezina

2016   Program Committee, American Urological Association (AUA) Summer Research Conference “Targeting Epigenetics and Genome Regulation to Improve Urologic Health,” Lithicum, MD, Chad Vezina

2014-   Editorial Board, American Journal of Clinical and Experimental Urology, Chad Vezina

2015-   Editorial Board, American Journal of Physiology – Renal, Chad Vezina

2015   Department of Veterans Affairs Review Panel 10P9B/SURG, Chad Vezina

2015   NIH/NIDDK Special Emphasis Review Panel ZDK1 GRB-S (O4), Chad Vezina

2015-   NIH/NIDDK DDK-D Subcommittee (Kidney, Urological and Hematological, review of career development awards), Chad Vezina

2016   NIH/NIDDK Special Emphasis Review Panel ZRG1 DKUS-G (90) S, Chad Vezina

2016   Department of Veterans Affairs Review Panel 10P9B/SURG, Chad Vezina


webmaster@surgery.wisc.edu Copyright © 2017 The Board of Regents of the University of Wisconsin System